An example is the case of Dr. Burrascano who testified at a 1993 Senate committee hearing on Lyme research, noting in particular,
"many serious improprieties" among NIH and CDC Lyme disease grant recipients, including funding that was being redirected to rheumatologic and arthritic problems rather than Lyme. Additionally, some of those grant recipients had serious conflicts of interest because they worked as paid medical consultants for insurance companies. Burrascano also implicated a major group of university-based researchers in working with government agencies to inappropriately influence the agendas of Lyme disease meetings.
Two months after the testimony he was notified that he was being "investigated" over an anonymous complaint.
The original decision handed down by the hearing panel in November of 2001 not only exonerated Dr. Burrascano from the charges, but also criticized the OPMC for attempting to prosecute a medical debate rather than actual medical misconduct. An excerpt from their decision remarked, "The Hearing Committee recognizes the existence of the current debate within the medical community over issues concerning management of patients with recurrent or long term Lyme disease. This appears to be a highly polarized and politicized conflict, as was demonstrated to this committee by expert testimony from both sides, each supported by numerous medical journal articles, and each emphatic that the opposite position was clearly incorrect. What clearly did emerge however, was that the Respondent's approach, while certainly a minority viewpoint, is one that is shared by many other physicians. We recognize that the practice of medicine may not always be an exact science, 'issued guidelines' are not regulatory, and patient care is frequently individualized."
The OPMC attempted to file an appeal and, in April of 2002, that appeal was refused by the Administrative Review Board who agreed with all of the findings of the original hearing panel.
http://www.publichealthalert.org/Articles/susanwilliams/world%20renowned%20doctor%20retires.htmlHere is another description of the phenomenon.
Physicians who have cared for persons with chronic Lyme disease have faced harassment at a minimum and for some, their careers have been ruined. Researchers who have seriously dedicated themselves to the scientific study of chronic Lyme disease in humans and/or animals have often found themselves attacked or marginalized. To persist in their researches would have resulted in virtual career suicide and some have been forced, by exigencies of survival, to leave the field. Laboratories that test extensively for Lyme disease, including use of direct detection methods such as PCR, have found themselves subjected to concerted smear campaigns and harassed. Whereas PCR is a well-accepted method in virtually all other infectious diseases, its clinical use for Lyme disease has also been marginalized. Direct detection methods developed more than a decade ago by some of this country’s finest physician-researchers and biomedical research scientists (Dorward DW, Schwan TG, Garon CF. Immmune Capture and Detection of Borrelia burgdorferi Antigens in Urine, Blood, or Tissues from Infected Ticks, Mice, Dogs, and Humans. J Clin Microbiol 1991;29:1162-1170 & Coyle PK, Deng Z, Schutzer SE, Belman AL, Benach J, Krupp L, Luft B. Detection of Borrelia burgdorferi antigens in cerebrospinal fluid. Neurology 1993;43:1093-1097 & Coyle PK, Schutzer SE, Deng Z, Krupp LB, Belman AL, Benach JL, Luft BJ. Detection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme disease. Neurology 1995;45:2010-5) have been moth-balled, I believe, for political and medical socioeconomic reasons.
Seronegativity, a well-recognized feature of spirochetal disease (e.g. in syphilis) is held to not need consideration despite early recognition of this phenomenon in Lyme disease, ironically, by a signer of the 2000 and 2006 IDSA Lyme disease guidelines (Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative Lyme Disease. Dissociation of T- and B-Lymphocyte Responses to Borrelia burgdorferi. N Engl. J Med 1988;319:1441-6).
~
State legislators have begun taking matters into their own hands and the states of Rhode Island, Connecticut, California, New York, Massachusetts and Minnesota have passed laws or promulgated policies protecting physicians who treat persons with chronic Lyme disease. Are these legislators stupid? Are they dupes of Lyme activists? Or can they see what is so obvious to the patients and to any good clinician, that Lyme disease can be a chronic infection that often requires a long-term treatment approach? Furthermore, as the disease spreads and more and more individuals are affected, legislator’s staffers, their wives, their children and they themselves are experiencing the effects of chronic Lyme disease.
http://www.lymedisease.org/news/lymepolicywonk/554.htmlDid you get that last paragraph? States are actually having to pass laws to protect doctors on one side of the controversy from treating patients in a manner that doctors on the other side disagree with.
From what I have read, there are some areas of the country where the atmosphere of intimidation is so pervasive that doctors won't even treat text book cases of early Lyme. (And btw, my mom was practically a textbook case of early acute Lyme disease, and her doctor misdiagnosed her as having cellulitis, apparently a
very common phenomenon.
That entire letter, from which the above paragraphs were excerpted, is very worthwhile and interesting reading.
As for your worries that long term ABX treatment contributes to the breeding of superbugs, that's valid, but before you go after people being treated for serious bacterial infections, you may want to go after the livestock feed industry. And after you're finished with them, you can go after all the rosacea and acne sufferers who are on long term ABX treatment.